Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AI Meets XRPL: Nimanode’s $NMA Presale Gains Momentum as AI Agents Set to Transform Web3 Automation
-
From Declaration to Action: Advancing Global Graft Fight under IAACA Steer
-
XRP News: $XDX Token Developed on XRP Nears Presale End in Just 12 Hours as Analysts Predict Major Surge Upon Exchange Listing
-
A National Crisis, a Local Solution: Win a Home and Help End Housing Insecurity
-
Afognak Native Corporation Hires New CEO
-
SIG Distro Expands its Offerings with New Product Lines
-
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
-
Fall of Mongolian coalition government could lead to severe economic downturn
-
JAMining Expands FCA-Regulated Cloud Mining Services Amid Surging Crypto Market Activity
-
CERE DEADLINE NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Secur
-
Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack
-
Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack
-
Direct Energy Regulated Services Announces Natural Gas Rates for June 2025
-
Pool Leak Detection Services Expands to El Paso & Las Cruces
-
Cheapest Car Insurance in Georgia (Only $24 a Month!)
-
USW: Trump’s 50% tariffs on steel and aluminum are a direct attack on Canadian jobs — Ottawa must act now
-
Global Advertising Giant WIEDEN AND KENNEDY UK LIMITED (WK) Announces Major Progress in Iraq Expansion and Deepens Strategic Partnership with OKX to Enhance Global Payroll Efficiency
-
Crypto Bubbles Come and Go: How Bitcoin Solaris’s Technology Aims for Stable, Long-Term Appreciation
-
Dr. James Morales Announces National Scholarship to Support Future Leaders in Music Education
-
Andrew Hillman Scholarship for Entrepreneurs Launches to Support Undergraduate Visionaries Across the United States
-
"TNFS": A Saudi-Led Initiative Sets Regional Benchmark in Tobacco Harm Reduction
-
Heron and Ito Group Announce Comprehensive Partnership in Key Regions
-
Global Blockchain Leaders Converge in New Delhi as Rickys Foundation Ignites the Next Wave of Decentralized Innovation
-
Faruqi & Faruqi Reminds Treace Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI
-
907 Heating and Plumbing Brings Trusted, Full-Service HVAC and Plumbing Expertise to Anchorage, Alaska
-
Author's Workplace Romance Inspires New Book Launch
-
CGC DEADLINE ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Sec
-
Dignity Made Launches to Fight Trafficking with Ethical Coconut Oil
-
Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model
-
Golden Goblet Awards Lineup Announced: Spotlight on This Year's Top Contenders
-
TMCI DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securitie
-
ispace Completes Success 8 of Mission 2 Milestones
-
New Data Show Genentech’s Itovebi Significantly Extended Survival in a Certain Type of HR-positive Advanced Breast Cancer
-
In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Ti
-
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
-
Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
-
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
-
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
-
ENHERTU® Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel as a Second-Line Therapy in Patients with HER2 Positive Unresectable or Metastatic Gastric Cancer in DESTINY-Gastric04 Pha
-
KEYTRUDA® (pembrolizumab) Plus Trodelvy® (sacituzumab govitecan-hziy) Reduced Risk of Disease Progression or Death by 35% Versus KEYTRUDA Plus Chemotherapy in First-Line PD-L1+ Metastatic Triple-Neg
-
Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025
-
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025
-
Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
-
Trodelvy® Plus Keytruda® Reduces Risk of Disease Progression or Death by 35% Versus Keytruda and Chemotherapy in First-Line PD-L1+ Metastatic Triple-Negative Breast Cancer
-
Todd Anniversary: From Research to Reality
-
Mythic Therapeutics Presents Compelling Efficacy Data from its Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Novel cMET- ADC, MYTX-011, in Non-Small Cell Lung Cancer at the American So
-
High School Students Named Best in America at the Council for Economic Education’s 2025 National Economics Challenge
-
Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
-
ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025
-
Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge
